| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $76.5M | -12.7% | +280.4% |
| Cost of Revenue | $34.3M | +25.8% | +323.5% |
| R&D Expense | $4.2M | +15.7% | +33.1% |
| SG&A Expense | $10.1M | +2.9% | +67.1% |
| Operating Income | -$38.1M | — | — |
| Pre-tax Income | -$38.6M | -2382.3% | -2523.6% |
| Income Tax | -$80K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $63.3M | — | — |
| Accounts Receivable | $24.7M | — | — |
| Inventory | $1.5M | — | — |
| Current Assets | $123.1M | — | — |
| Total Assets | $197.0M | — | +1354.5% |
| Current Liabilities | $113.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$58.7M | — | — |
| Investing Cash Flow | -$15.6M | — | — |
| Financing Cash Flow | $130.4M | — | — |
| -430.7% |
| Net Income | -$38.6M | -2378.2% | -2477.3% |
| EPS (Basic) | -$0.25 | -132.1% | -146.0% |
| EPS (Diluted) | -$0.25 | -132.1% | -146.0% |
| +2865.8% |
| Total Liabilities | $159.8M | +1410.7% | +2718.3% |
| Stockholders' Equity | $37.2M | +465.5% | +840.1% |